维普期刊资源整合服务平台（V6.5）

121篇 您的检索式：作者名="Curigliano G"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	The triple - negative subtype: newideas for the poorest prognosis breast cancer 显示文摘	Curigliano G Goldhirsch A	2011	Natl Cancer Inst Monogr2011，43，：	1
2	Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer显示文摘	CURIGLIANO G VIALE G BAGNARDI V	2009	J Clin Oncol2009，27，34：	1
3	The triple-negative subtype: new ideas for the poorest prognosis breast cancer显示文摘	CURIGLIANO G GOLDHIRSCH A	2011	J Natl Canc- er Inst Monogr2011，2011，43：	1
4	Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features 显示文摘	Curigliano G Rigo R Colleoni M	2004	Clin Breast Cancer2004，65，2：	1
5	Randomized phase II study of sunitinib versus standard of care for patients with pre- viously treated advanced triple-negative breast cancer 显示文摘	Curigliano G Pivot X Cortrs J	2013	Breast2013，22，5：	1
6	High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy显示文摘	Zurrida S Bagnardi V Curigliano G	2013	Eur J Cancer2013，49，15：	1
7	Adjuvant therapy for very young women with breast cancer:response according to biologic and endocrine features显示文摘	Curigliano G Rigo R Colleoni M	2004	Clin Breast Cancer2004，5，2：	1
8	Challenges and prospects o{ immunotherapy as cancer treatment显示文摘	Rescigno M Avogadri F Curigliano G	2007	Bioehim Biopbys Acta2007，1776，：	1
9	Molecular pathways:human leukocyte antigen G(HLA-G)显示文摘	Curigliano G Criscitiello C Gelao L	2013	Clin Cancer Res2013，19，20：	1
10	Gemcitabineinduced systemic capillary leak syndrome 显示文摘	Curigliano G Franceschelli L	2001	Ann Oncol2001，12，11：	1
11	Cardiovascular toxicity in- duced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines显示文摘	Curigliano G Cardinale D Suter T	2012	Annals of Oncology2012，23，7：	1
12	Adjuvant therapy for very young women with breast cancer: response accord- ing to biologic and endocrine features 显示文摘	Curigliano G Rigo R Colleoni M	2004	Clin Breast Cancer2004，65，2：	1
13	HER2 signaling pathway and trastuzumab cardiotoxicity显示文摘	Criscitiello C Curigliano G	2013	Future Oncol2013，9，2：	1
14	Challenges and prospects of immunotherapy as cancer treatment显示文摘	Rescigno M Avogadri F Curigliano G	2007	BBA-Reviews on Cancer2007，1776，1：	1
15	Breast carcinoma in elderlywomen: features ofdisease presentation, choice of localand systemic treatments compared with younger postmenopausal patients 显示文摘	Gennari R Curigliano G Rotmensz N	2004	Cancer2004，101，6：	1
16	Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with the younger postmenopa- sual patients 显示文摘	Gennari R Curigliano G Rotmensz N	2004	Cancer2004，101，6：	1
17	Adjuvant therapy for very young women with breast cancer:response according to biologic and endocrine features显示文摘	Curigliano G Rigo R Colleoni M	2004	Clin Breast Cancer2004，5，2：	1
18	Immunology and breastcancer:therapeutic cancer vaccines显示文摘	Curigliano G Rescigno M Goldhirsch A	2007	Breast2007，16，2：	1
19	Breast cancer vaccines:a clinical reality or fairy tale?显示文摘	Curigliano G Spitaleri G Pietri E	2006	Ann Oncol2006，17，5：	1
20	Adjuvant therapy for very young women with breast cancer:Response according to biologic and endocrine features显示文摘	CURIGLIANO G RIGO R COLLEONI M		0，，02：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示